TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive NTP Bioassay Reports Will Include Other Tests In Assessing Potential Human Risk January 23, 1981
TCL Archive Decision To Stop NSABP P-4 Study Before It Starts Shocks Clinical Trialists. March 2, 2007